The quantitative polygenic risk scores are designed to indicate the overall genetic risk for epilepsy.
A study by the researchers found that the scores accurately differentiate between healthy and epilepsy patients on a cohort level. The scores can also distinguish people with generalised and focal epilepsies.
Prediction of epilepsy development after the first seizure is considered complex. Genetic risk scores are intended to support diagnosis and early treatment of the disease.